Short answer
Olema Pharmaceuticals, Inc. (OLMA) filed an 8-K current report with the SEC on March 16, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Full-year 2025 financial results reported March 16, 2026.
Olema Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Full-year 2025 financial results reported March 16, 2026
- Full details in accompanying press release exhibit: primary source for revenue, cash, and pipeline spend figures
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Olema Pharmaceuticals, Inc. 8-K filings
Get the next OLMA 8-K as it lands
Follow OLMA for push alerts, or ask the research agent what this filing means.